Volitionrx Limited (VNRX) CMO Jason Terrell Resigns

November 25, 2022 9:26 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Volitionrx Limited (NYSE: VNRX) disclosed:

On November 22, 2022, Dr. Jason Terrell tendered written notice to VolitionRx Limited (the “Company”) of his resignation as Chief Medical Officer of the Company, effective as of November 18, 2022. The Company thanks Dr. Terrell for his contributions to the Company and wishes him success in his future endeavours.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes